Publications by authors named "R Balaraman"

Claim this Profile
6
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial.
Fatima Cardoso, William Jacot, Sherko Kuemmel, Sudeep Gupta, Felipe Cruz, Rama Balaraman

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combined network pharmacology and experimental approach to investigate the mechanisms of curcumin on diabetes through the adipocytokine signaling pathway.
Ghanshyam Parmar, Jay Mukesh Chudasama, Rajesh A Maheshwari, Denish Hinsu, Ashish Shah, Ramachandran Balaraman

Naunyn Schmiedebergs Arch Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ERG1A K Channel Is More Abundant in Muscle from Cancer Patients Than that from Healthy Humans.
Sandra Zampieri, Marco Sandri, Joseph L Cheatwood, Rajesh P Balaraman, Luke B Anderson

Diagnostics (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorado tick fever virus induces apoptosis in human endothelial cells to facilitate viral replication.
Sarah Owen, Caitlyn Gaffney, Luis Grado, Michelle L Woodson, Judy A King, Rajesh P Balaraman

Ticks Tick Borne Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals.
Suresh Velumani, Patel Arpita, Ramachandran Balaraman

Indian J Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis